Verition Fund Management
RXII

Verition Fund Management’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Verition Fund Management’s Portfolio RXII Stock Details RXII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-16,489
Closed -$50K – 1007
2014
Q2 		$50K Buy
+16,489
New +$50K 0.01% 633
2014
Q1 		– Sell
-11,391
Closed -$56K – 760
2013
Q4 		$56K Buy
+11,391
New +$56K 0.01% 475

Other funds holding RXII

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
SGAM
Smith Group Asset Management Dallas, Texas $2.46B AUM 57.16% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Verition Fund Management's RXII Position: Q3 2014 in Review

Verition Fund Management sold out of GALENA BIOPHARMA INC COM (RXII) in Q3 2014, closing a stake of 16,489 shares — an estimated $50K sold.

Verition Fund Management first reported a position in RXII in Q4 2013 and held it in 2 quarters. The position peaked at $56K in Q4 2013. 85 funds tracked by Wall St. Rank hold RXII as of Q3 2014.

  • Verition Fund Management reported no remaining GALENA BIOPHARMA INC COM position as of Q3 2014 after selling out during the quarter.
  • Verition Fund Management sold 16,489 GALENA BIOPHARMA INC COM shares in Q3 2014, an estimated $50K.
  • Verition Fund Management first reported a position in GALENA BIOPHARMA INC COM in Q4 2013 and held it in 2 quarters.
  • Verition Fund Management's GALENA BIOPHARMA INC COM position peaked at $56K in Q4 2013.
  • 85 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q3 2014.

Based on Verition Fund Management's 13F filing for Q3 2014, filed 14 Nov 2014.